218 related articles for article (PubMed ID: 23070765)
1. Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery.
Kichler A; Mason AJ; Marquette A; Bechinger B
Methods Mol Biol; 2013; 948():85-103. PubMed ID: 23070765
[TBL] [Abstract][Full Text] [Related]
2. Histidine-Rich Cationic Cell-Penetrating Peptides for Plasmid DNA and siRNA Delivery.
Kichler A; Mason AJ; Marquette A; Bechinger B
Methods Mol Biol; 2019; 1943():39-59. PubMed ID: 30838608
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional CPP polymer system for tumor-targeted pDNA and siRNA delivery.
Dohmen C; Wagner E
Methods Mol Biol; 2011; 683():453-63. PubMed ID: 21053149
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic polyalanine modified hyperbranched polyethylenimine as high efficient pDNA and siRNA carrier.
Guo Z; Tian H; Lin L; Chen J; He C; Tang Z; Chen X
Macromol Biosci; 2014 Oct; 14(10):1406-14. PubMed ID: 24948023
[TBL] [Abstract][Full Text] [Related]
6. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy.
Duguid JG; Li C; Shi M; Logan MJ; Alila H; Rolland A; Tomlinson E; Sparrow JT; Smith LC
Biophys J; 1998 Jun; 74(6):2802-14. PubMed ID: 9635734
[TBL] [Abstract][Full Text] [Related]
7. Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.
Ivanova EA; Maslov MA; Kabilova TO; Puchkov PA; Alekseeva AS; Boldyrev IA; Vlassov VV; Serebrennikova GA; Morozova NG; Zenkova MA
Org Biomol Chem; 2013 Nov; 11(41):7164-78. PubMed ID: 24057052
[TBL] [Abstract][Full Text] [Related]
8. Histidine-lysine peptides as carriers of nucleic acids.
Leng Q; Goldgeier L; Zhu J; Cambell P; Ambulos N; Mixson AJ
Drug News Perspect; 2007 Mar; 20(2):77-86. PubMed ID: 17440630
[TBL] [Abstract][Full Text] [Related]
9. Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA.
Maslov MA; Kabilova TO; Petukhov IA; Morozova NG; Serebrennikova GA; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):182-93. PubMed ID: 22138073
[TBL] [Abstract][Full Text] [Related]
10. Optimising histidine rich peptides for efficient DNA delivery in the presence of serum.
Mason AJ; Leborgne C; Moulay G; Martinez A; Danos O; Bechinger B; Kichler A
J Control Release; 2007 Mar; 118(1):95-104. PubMed ID: 17254661
[TBL] [Abstract][Full Text] [Related]
11. Arginine-rich hydrophobic polyethylenimine: potent agent with simple components for nucleic acid delivery.
Parhiz H; Hashemi M; Hatefi A; Shier WT; Amel Farzad S; Ramezani M
Int J Biol Macromol; 2013 Sep; 60():18-27. PubMed ID: 23680600
[TBL] [Abstract][Full Text] [Related]
12. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
[TBL] [Abstract][Full Text] [Related]
13. Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.
Sharma R; Shivpuri S; Anand A; Kulshreshtha A; Ganguli M
Mol Pharm; 2013 Jul; 10(7):2588-600. PubMed ID: 23725377
[TBL] [Abstract][Full Text] [Related]
14. Cationic amphipathic histidine-rich peptides for gene delivery.
Kichler A; Mason AJ; Bechinger B
Biochim Biophys Acta; 2006 Mar; 1758(3):301-7. PubMed ID: 16540079
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery.
Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A
J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204
[TBL] [Abstract][Full Text] [Related]
16. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
[TBL] [Abstract][Full Text] [Related]
17. The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes.
Mason AJ; Martinez A; Glaubitz C; Danos O; Kichler A; Bechinger B
FASEB J; 2006 Feb; 20(2):320-2. PubMed ID: 16352649
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
19. Reversibly stable thiopolyplexes for intracellular delivery of genes.
Cavallaro G; Campisi M; Licciardi M; Ogris M; Giammona G
J Control Release; 2006 Oct; 115(3):322-34. PubMed ID: 17028038
[TBL] [Abstract][Full Text] [Related]
20. Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate.
Govindarajan S; Sivakumar J; Garimidi P; Rangaraj N; Kumar JM; Rao NM; Gopal V
Biomaterials; 2012 Mar; 33(8):2570-82. PubMed ID: 22192536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
